Park Jee Soo, Kim Jongchan, Elghiaty Ahmed, Ham Won Sik
Department of Urology and Urological Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea Department of Urology, Tanta University College of Medicine, Tanta, Egypt.
Medicine (Baltimore). 2018 Sep;97(37):e12390. doi: 10.1097/MD.0000000000012390.
Testicular cancer (TCa) has a relatively rare incidence and mortality, but has not been thoroughly evaluated. We analyzed global variations and recent trends in TCa incidence and mortality.Age-standardized rates (ASRs) of TCa incidence and mortality were retrieved from the GLOBOCAN 2012 database. Temporal patterns were assessed using data obtained from the Cancer Incidence in Five Continents (volumes I-X) and World Health Organization Mortality databases. The incidence and mortality trends over the last 10 years were analyzed using join point analysis.Western and Northern Europe had the highest incidence of TCa (ASR = 8.7 and 7.2, respectively), with most countries showing an increase in incidence rates except for China, which had a stable incidence. Incidence rates were markedly increased in Southern European countries (average annual percent change of 6.8% in Croatia and 6.1% in Spain) but were attenuated in western Europe. The highest mortality rates were observed in western Asia (ASR = 0.7), with most countries showing a decrease in mortality.While the incidence of TCa has increased, mortality from TCa has decreased in most countries. More socioeconomically developed countries had a higher incidence of TCa with lower mortality.
睾丸癌(TCa)的发病率和死亡率相对较低,但尚未得到充分评估。我们分析了全球睾丸癌发病率和死亡率的变化及近期趋势。从GLOBOCAN 2012数据库中检索了睾丸癌发病率和死亡率的年龄标准化率(ASR)。利用从《五大洲癌症发病率》(第一至十卷)和世界卫生组织死亡率数据库获得的数据评估时间模式。使用连接点分析对过去10年的发病率和死亡率趋势进行了分析。西欧和北欧的睾丸癌发病率最高(ASR分别为8.7和7.2),除中国发病率稳定外,大多数国家的发病率都有所上升。南欧国家的发病率显著上升(克罗地亚的年均变化率为6.8%,西班牙为6.1%),但在西欧有所减缓。西亚的死亡率最高(ASR = 0.7),大多数国家的死亡率呈下降趋势。虽然睾丸癌的发病率有所上升,但大多数国家的睾丸癌死亡率有所下降。社会经济更发达的国家睾丸癌发病率较高,但死亡率较低。